4-8441430-T-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_152544.3(TRMT44):āc.608T>Cā(p.Ile203Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0000719 in 1,515,312 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000085 ( 0 hom., cov: 33)
Exomes š: 0.000070 ( 0 hom. )
Consequence
TRMT44
NM_152544.3 missense
NM_152544.3 missense
Scores
4
15
Clinical Significance
Conservation
PhyloP100: 3.72
Genes affected
TRMT44 (HGNC:26653): (tRNA methyltransferase 44 homolog) The protein encoded by this gene is a putative tRNA methyltransferase found in the cytoplasm. Defects in this gene may be a cause of partial epilepsy with pericentral spikes (PEPS), but that has not been proven definitively. [provided by RefSeq, May 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.07404995).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRMT44 | NM_152544.3 | c.608T>C | p.Ile203Thr | missense_variant | 1/11 | ENST00000389737.5 | NP_689757.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRMT44 | ENST00000389737.5 | c.608T>C | p.Ile203Thr | missense_variant | 1/11 | 5 | NM_152544.3 | ENSP00000374387 | P2 | |
TRMT44 | ENST00000513449.6 | c.-76+2388T>C | intron_variant | 1 | ENSP00000424643 | A2 | ||||
TRMT44 | ENST00000504134.1 | c.470T>C | p.Ile157Thr | missense_variant | 1/2 | 3 | ENSP00000434207 | |||
TRMT44 | ENST00000528167.1 | n.626T>C | non_coding_transcript_exon_variant | 1/3 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000855 AC: 13AN: 152096Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
13
AN:
152096
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000308 AC: 4AN: 129962Hom.: 0 AF XY: 0.0000425 AC XY: 3AN XY: 70528
GnomAD3 exomes
AF:
AC:
4
AN:
129962
Hom.:
AF XY:
AC XY:
3
AN XY:
70528
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000704 AC: 96AN: 1363216Hom.: 0 Cov.: 31 AF XY: 0.0000658 AC XY: 44AN XY: 668672
GnomAD4 exome
AF:
AC:
96
AN:
1363216
Hom.:
Cov.:
31
AF XY:
AC XY:
44
AN XY:
668672
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000855 AC: 13AN: 152096Hom.: 0 Cov.: 33 AF XY: 0.000108 AC XY: 8AN XY: 74294
GnomAD4 genome
AF:
AC:
13
AN:
152096
Hom.:
Cov.:
33
AF XY:
AC XY:
8
AN XY:
74294
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
2
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 15, 2023 | The c.608T>C (p.I203T) alteration is located in exon 1 (coding exon 1) of the TRMT44 gene. This alteration results from a T to C substitution at nucleotide position 608, causing the isoleucine (I) at amino acid position 203 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
L
MutationTaster
Benign
D;N
PrimateAI
Uncertain
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Uncertain
D
Sift4G
Uncertain
D
Vest4
MutPred
Gain of disorder (P = 0.017);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at